摘要
目的 探究胆汁反流性胃炎经莫沙比利联合铝碳酸镁片治疗的临床效果。方法 选取我院2011年2月~2015年2月收治的128例胆汁反流性胃炎患者,随机分成观察组、对照组,各64例。观察组通过莫沙必利、铝碳酸镁片治疗,对照组采取莫沙必利治疗,对比两组临床效果、不良反应情况。结果 观察组的治疗总有效率为95.31%,对照组的治疗总有效率为81.25%,差异具有统计学意义,P〈0.05。且两组患者均没有产生不良反应情况。结论 胆汁反流性胃炎通过莫沙必利联合铝碳酸镁片治疗,能够有效的提高临床疗效,同时不会产生不良反应情况。
Objective To explore the clinical effect of bile reflux gastritis after mosapride joint hydrotalcid sheet treatment. Methods In our hospital from February 2011 to February 2015 were treated 128 cases of bile reflux gastritis were randomly divided into observation group and control group,64 cases. Through the observation group mosapride,aluminum magnesium carbonate tablets in the treatment and control group taking mosapride,compared two groups of clinical effects,adverse reactions. Results The observation group total effective rate was 95.31%, treatment group total effective rate was 81.25%,the difference was significant,P ＆lt; 0.05. And two groups of patients had no significant adverse reactions. Conclusion Bile reflux gastritis by mosapride joint hydrotalcid sheet treatment,can effectively improve the clinical efficacy,while no significant adverse reactions.
出处
《中国卫生标准管理》
2016年第12期82-83,共2页
China Health Standard Management
